Volatile Stocks: DARA Biosciences Inc. (NASDAQ:DARA), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), StemCells Inc. (NASDAQ:STEM), TG Therapeutics, Inc. (NASDAQ:TGTX), Onconova Therapeutics Inc. (NASDAQ:ONTX)

DARA BioSciences, Inc. (NASDAQ:DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, on 3 June announced the launch of a smartphone app to provide cancer patients an educational resource to help improve oral care and management of oral mucositis. DARA Biosciences Inc. (NASDAQ:DARA) weekly performance is 0.79%. On last trading day company shares ended up $1.15. Analysts mean target price for the company is $2.00. DARA Biosciences Inc. (NASDAQ:DARA) distance from 50-day simple moving average (SMA50) is -35.16%.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) announced that the Anesthetic and Analgesic Drug Products Advisory Committee of the Food and Drug Administration (FDA) has provided an assessment of potential cardiovascular risk associated with products in the class of peripherally-active opioid receptor antagonists (PAMORAS) and recommendations regarding the necessity, timing, design and size of cardiovascular outcomes trials to support approval of products in this class for the proposed indication of opioid-induced constipation (OIC) in patients taking opioids for chronic pain. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) shares advanced 9.23% in last trading session and ended the day on $4.22. PGNX gross Margin is 92.00% and its return on assets is -32.20%.Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) quarterly performance is -7.95%.

For the first quarter of 2014, StemCells Inc. (NASDAQ:STEM) on 14 may reported a net loss of approximately $7,620,000, or $(0.14) per share, compared with a net loss of approximately $6,416,000, or $(0.17) per share, for the first quarter of 2013. StemCells Inc. (NASDAQ:STEM) shares moved up 7.69% in last trading session and was closed at $1.54, while trading in range of $1.43 – $1.55. StemCells Inc. (NASDAQ:STEM) year to date (YTD) performance is 25.20%.

TG Therapeutics, Inc. (NASDAQ:TGTX), an innovative clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, on 12 may announced its results for the first quarter ended March 31, 2014 and recent company developments. The consolidated net loss for the first quarter ended March 31, 2014 was $7.5 million, or $0.25 per share, compared to a consolidated net loss of $3.7 million during the comparable quarter in 2013, representing an increase in consolidated net loss of $3.8 million. TG Therapeutics, Inc. (NASDAQ:TGTX) ended the last trading day at $8.82. Company weekly volatility is calculated as 11.19% and price to cash ratio as 6.20.TG Therapeutics, Inc. (NASDAQ:TGTX) showed a positive weekly performance of 36.74%.

Onconova Therapeutics Inc. (NASDAQ:ONTX) announced on 12 may, Total net revenue was $0.4 million for the first quarter of 2014, compared to $1.1 million for the first quarter of 2013. Onconova Therapeutics Inc. (NASDAQ:ONTX) weekly performance is 20.75%. On last trading day company shares ended up $5.12. Analysts mean target price for the company is $11.50. Onconova Therapeutics Inc. (NASDAQ:ONTX) distance from 50-day simple moving average (SMA50) is -3.17%.